Vasca LifeSite Hemodialysis System Offers Alternative To Catheters, Grafts
This article was originally published in The Gray Sheet
Executive Summary
Vasca says it expects to commercialize its LifeSite hemodialysis access system in the U.S. by the end of 1999.
You may also be interested in...
Device Firms Garner 31% Of Venture-Backed Health Care Funding In Q2
Aggregate investments of $250 mil. in medical device and instrument companies by venture capital firms during the second quarter represented 31% of the nearly $800 mil. in total health care financings in the three months ended June 30, according to a recent PricewaterhouseCoopers Money Tree Survey.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.